CIK 0001651311
MRUS Merus N.V.
Insider trading from SEC Form 4. Last filing Dec 30, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Signals
Open-market buys and sells at Merus N.V., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | A/s Genmab owner buy | $7.5B 76,922,983 shares | +106% | - | |
| 37Weak | A/s Genmab owner buy | $79M 815,444 shares | +1% | - | |
| 32Weak | A/s Genmab owner buy | $27M 278,441 shares | +0% | - | |
| 27Weak | A/s Genmab owner buy | $26M 271,547 shares | +0% | - | |
| 16Weak | Harry Shuman VP Controller, PAO sell | $163k 1,700 shares | -13% | - | |
| 32Weak | Harry Shuman VP Controller, PAO sell | $796k 8,300 shares | -43% | - | |
| 30Weak | Peter B. Silverman COO & GC sell | $1.5M 25,000 shares | -100% | - | |
| 30Weak | Peter B. Silverman COO & GC sell | $1.3M 23,500 shares | -351% | - | |
| 30Weak | Peter B. Silverman COO & GC sell | $1.8M 34,000 shares | -100% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnote | +2,978 | $97.00 | $289k | 72,831,487 | Dec 30, 2025 |
| Dec 29, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnote | +1,052,806 | $97.00 | $102M | 73,884,293 | Dec 30, 2025 |
| Dec 29, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnote | -75,867,199 | $97.00 | $7.4B | 0 | Dec 30, 2025 |
| Dec 22, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnotes | +15,710 | $97.00 | $1.5M | 72,028,775 | Dec 29, 2025 |
| Dec 23, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnotes | +561,042 | $97.00 | $54M | 72,589,817 | Dec 29, 2025 |
| Dec 24, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnotes | +96,082 | $97.00 | $9.3M | 72,685,899 | Dec 29, 2025 |
| Dec 26, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnotes | +142,610 | $97.00 | $14M | 72,828,509 | Dec 29, 2025 |
| Dec 18, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnotes | +212,177 | $97.00 | $21M | 71,946,801 | Dec 22, 2025 |
| Dec 19, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnotes | +66,264 | $97.00 | $6.4M | 72,013,065 | Dec 22, 2025 |
| Dec 16, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnotes | +120,752 | $97.00 | $12M | 71,583,829 | Dec 18, 2025 |
| Dec 17, 2025 | A/s Genmab owner | POpen-market purchase Common Shares, nominal value EUR 0.09 per shareindirect: See footnotes | +150,795 | $97.00 | $15M | 71,734,624 | Dec 18, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -13,193 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Maxine Gowen director | DDisposition to issuer Share Option (right to buy)derivative | -13,193 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Jason Haddock director | DDisposition to issuer Share Option (right to buy)derivative | -13,193 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Paolo Pucci director | DDisposition to issuer Share Option (right to buy)derivative | -13,193 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | UTender of shares Common Sharesindirect: Ante S Lundberg Qualified Annuity Interest Trust XI | -30,297 | $97.00 | $2.9M | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | UTender of shares Common Shares | -11,002 | $97.00 | $1.1M | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Fabian Zohren Chief Medical Officer | DDisposition to issuer Share Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Peter B. Silverman COO & GC | DDisposition to issuer Share Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | UTender of shares Common Shares | -73,576 | $97.00 | $7.1M | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -13,193 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Victor Sandor director | DDisposition to issuer Share Option (right to buy)derivative | -13,193 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -100,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -7,600 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Paolo Pucci director | DDisposition to issuer Share Option (right to buy)derivative | -8,844 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Jason Haddock director | DDisposition to issuer Share Option (right to buy)derivative | -17,688 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -8,844 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Fabian Zohren Chief Medical Officer | DDisposition to issuer Share Option (right to buy)derivative | -183,943 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | UTender of shares Common Sharesindirect: Ante S Lundberg Qualified Annuity Int Trust X | -16,372 | $97.00 | $1.6M | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Victor Sandor director | DDisposition to issuer Share Option (right to buy)derivative | -8,844 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -13,193 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -107,300 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Peter B. Silverman COO & GC | DDisposition to issuer Share Option (right to buy)derivative | -125,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Maxine Gowen director | DDisposition to issuer Share Option (right to buy)derivative | -8,844 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -8,844 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -372,924 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Paolo Pucci director | DDisposition to issuer Share Option (right to buy)derivative | -14,414 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -16,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | UTender of shares Common Sharesindirect: Katrina Lundberg 2018 Irrevocable Trust | -9,191 | $97.00 | $892k | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -8,844 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -14,414 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -14,414 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Peter B. Silverman COO & GC | DDisposition to issuer Share Option (right to buy)derivative | -107,300 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Maxine Gowen director | DDisposition to issuer Share Option (right to buy)derivative | -14,414 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Victor Sandor director | DDisposition to issuer Share Option (right to buy)derivative | -14,414 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -16,604 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -4,700 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Paolo Pucci director | DDisposition to issuer Share Option (right to buy)derivative | -16,604 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | UTender of shares Common Sharesindirect: Madeleine Lundberg 2018 Irrevocable Trust | -9,191 | $97.00 | $892k | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -14,414 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -14,414 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Peter B. Silverman COO & GC | DDisposition to issuer Share Option (right to buy)derivative | -3,900 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -16,604 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Victor Sandor director | DDisposition to issuer Share Option (right to buy)derivative | -16,604 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Maxine Gowen director | DDisposition to issuer Share Option (right to buy)derivative | -16,604 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Victor Sandor director | DDisposition to issuer Share Option (right to buy)derivative | -6,120 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Maxine Gowen director | DDisposition to issuer Share Option (right to buy)derivative | -12,240 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -6,120 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -12,400 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Paolo Pucci director | DDisposition to issuer Share Option (right to buy)derivative | -6,120 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | UTender of shares Common Sharesindirect: Kristian Ante Lundberg 2018 Irrevocable Trust | -9,192 | $97.00 | $892k | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Peter B. Silverman COO & GC | DDisposition to issuer Share Option (right to buy)derivative | -12,714 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -16,604 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -16,604 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -6,120 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Victor Sandor director | DDisposition to issuer Share Option (right to buy)derivative | -8,631 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Maxine Gowen director | DDisposition to issuer Share Option (right to buy)derivative | -7,957 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -8,631 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -5,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Paolo Pucci director | DDisposition to issuer Share Option (right to buy)derivative | -17,262 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | UTender of shares Common Sharesindirect: Emily Lundberg 2018 Irrevocable Trust | -9,192 | $97.00 | $892k | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Peter B. Silverman COO & GC | DDisposition to issuer Share Option (right to buy)derivative | -104,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -6,120 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -8,631 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -6,120 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Victor Sandor director | DDisposition to issuer Share Option (right to buy)derivative | -17,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -14,149 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -14,500 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | DDisposition to issuer Share Option (right to buy)derivative | -312,620 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Peter B. Silverman COO & GC | DDisposition to issuer Share Option (right to buy)derivative | -20,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -8,631 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -8,631 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -17,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -7,669 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -23,420 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | DDisposition to issuer Share Option (right to buy)derivative | -351,628 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Peter B. Silverman COO & GC | DDisposition to issuer Share Option (right to buy)derivative | -83,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -17,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -5,650 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -5,650 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -700 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Len Kanavy director | DDisposition to issuer Share Option (right to buy)derivative | -8,500 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | DDisposition to issuer Share Option (right to buy)derivative | -300,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Gregory D Perry Chief Financial Officer & PFO | DDisposition to issuer Share Option (right to buy)derivative | -5,650 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -4,983 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -4,983 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Harry Shuman VP Controller, PAO | DDisposition to issuer Share Option (right to buy)derivative | -27,550 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Sven Ante Lundberg President, CEO & PEO | DDisposition to issuer Share Option (right to buy)derivative | -360,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Mark T Iwicki director | DDisposition to issuer Share Option (right to buy)derivative | -8,500 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | Anand Mehra director | DDisposition to issuer Share Option (right to buy)derivative | -8,500 | $0.00 | $0 | 0 | Dec 12, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- A/s Genmabowner
- Maxine Gowendirector
- Jason Haddockdirector
- Mark T Iwickiceo, officer, director
- Len Kanavydirector
- Sven Ante LundbergPresident, CEO & PEO
- Anand Mehradirector
- Gregory D PerryChief Financial Officer & PFO
- Paolo Puccidirector
- Victor Sandordirector
- Harry ShumanVP Controller, PAO
- Peter B. SilvermanCOO & GC
- Fabian ZohrenChief Medical Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.